A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT00496132 · TERMINATED
Trial details
- NCT number
- NCT00496132
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-27
- Primary completion
- 2009-06-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.